Unknown NA INTERVENTIONAL 2-arm NCT04205526

Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke (ConTRAstroke)

Canadian Platform for Trials With Non-Invasive Brain Stimulation: Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke - A Feasibility Trial (Canstim: ConTRA-Stroke-F)

Sponsor: Ottawa Heart Institute Research Corporation

Conditions Feasibility Study

Interventions Active rTMS Sham TMS

Updated 7 times since 2020 Last updated: Jun 17, 2022 Started: Jan 1, 2021 Primary completion: Apr 1, 2024 Completion: Jun 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Feasibility Study and is currently ongoing. Ottawa Heart Institute Research Corporation leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Aug 2024 — Sep 2024 [monthly]

Unknown NA

Status: Recruiting → Unknown
Jul 2024 — Aug 2024 [monthly]

Recruiting NA
Jul 2022 — Jul 2024 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting
Jan 2022 — Jul 2022 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status

▶ Show 2 earlier versions

Jan 2021 — Jan 2022 [monthly]

Not Yet Recruiting NA
Jan 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ottawa Heart Institute Research Corporation
Thiel, Alexander, M.D.

Data source: Thiel, Alexander, M.D.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada